“Bimekizumab Efficacy in Patients With Moderate to Severe Plaque Psoriasis and Hypertension, Elevated Body Mass Index, or Hyperglycemia: Results Through 3 Years of Treatment in 5 Phase 3 3b Trials”. 2024. SKIN The Journal of Cutaneous Medicine 8 (1): s308. https://doi.org/10.25251/skin.8.supp.308.